Aldeyra Therapeutics (ALDX) – Hot Corp. News
-
Aldeyra Therapeutics (ALDX) Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap
-
Aldeyra Therapeutics (ALDX) received minutes from a late-cycle review meeting with FDA for reproxalap
-
-
-
-
-
-
-
-
-
-
-
Back to ALDX Stock Lookup